These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25372945)

  • 41. A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
    Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
    PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
    Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
    Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
    Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M
    Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
    Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
    ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BMI1 promotes the progression of laryngeal squamous cell carcinoma.
    Chen H; Zhou L; Wan G; Dou T; Tian J
    Oral Oncol; 2011 Jun; 47(6):472-81. PubMed ID: 21482478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY; Park YS; Nam JH
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BMI1 as a novel target for drug discovery in cancer.
    Cao L; Bombard J; Cintron K; Sheedy J; Weetall ML; Davis TW
    J Cell Biochem; 2011 Oct; 112(10):2729-41. PubMed ID: 21678481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
    Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
    Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
    Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bmi1 Suppresses Adipogenesis in the Hematopoietic Stem Cell Niche.
    Hu T; Kitano A; Luu V; Dawson B; Hoegenauer KA; Lee BH; Nakada D
    Stem Cell Reports; 2019 Sep; 13(3):545-558. PubMed ID: 31257132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.
    Kim HG; Kim DJ; Li S; Lee KY; Li X; Bode AM; Dong Z
    J Biol Chem; 2012 Sep; 287(38):31920-8. PubMed ID: 22843710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
    Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
    Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing of Bmi-1 gene by RNA interference enhances sensitivity to doxorubicin in breast cancer cells.
    Wu X; Liu X; Sengupta J; Bu Y; Yi F; Wang C; Shi Y; Zhu Y; Jiao Q; Song F
    Indian J Exp Biol; 2011 Feb; 49(2):105-12. PubMed ID: 21428211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Evaluation of BMI1 Posttranslational Modifications During Retinal Degeneration to Understand BMI1 Action on Photoreceptor Death Execution.
    Mbefo MK; Arsenijevic Y
    Adv Exp Med Biol; 2018; 1074():359-365. PubMed ID: 29721964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.